Across TCGA pan-cancer cohorts, SPOCK3 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SPOCK3 data layer compared with 21 for mass-spec protein and 7 for mutation status.
The strongest signal is observed in glioblastoma multiforme (GBM), where higher SPOCK3 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated SPOCK3 expression acts as an unfavorable survival marker.
GBM are the cancer types where SPOCK3 mass-spec protein most reproducibly stratifies survival.